Medicare to cover 癌 CAR-Ts therapies
Aug 7 (Reuters) - The U.S. 中心s for Medicare and Medicaid Services (CMS) 完結するd its 決定／判定勝ち（する） to cover CAR-T 独房 therapies, the 機関 said on Wednesday.
CMS, which runs the 連邦の 政府's healthcare 計画（する） for 上級のs, will cover the therapies when 供給するd in 確かな healthcare 施設s, the regulator said https://www.cms.gov/medicare-ニュース報道-database/詳細（に述べる）s/nca-決定／判定勝ち（する）-覚え書き.aspx?NCAId=291.
Chimeric antigen receptor T-独房 therapy, known as CAR-T, 伴う／関わるs 製図／抽選 white 血 独房s from a 患者, 過程ing them in the lab to 的 癌, and infusing the 独房s 支援する into the 患者. (報告（する）／憶測ing by Ankur Banerjee in Bengaluru; Editing by Shinjini Ganguli)
